Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.1 (
ACS
)
78,556
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Plasmonic metal nanostructures, in colloidal or surface-supported forms, have been extensively studied in the context of metamaterials design and applications, in particular as refractometric sensing platforms. Recently, high refractive index (high-n) dielectric subwavelength structures have been experimentally shown to support strong Mie scattering resonances, predicted to exhibit analogous refractive index sensing capabilities. Here we present the first experimental demonstration of the use of supported high-n dielectric nano/microparticle ensembles as refractive index sensing platforms, using cuprous oxide as a model high-n material. Single-crystalline Cu
2
O particles were deposited on transparent substrates using a chemical deposition scheme, showing well-defined electric and magnetic dipolar resonances (
EDR
and MDR, respectively) in the visible range, which change in intensity and wavelength upon changing the medium refractive index (n
m
). The significant modulation of the MDR intensity when n
m
is modified appears to be the most valuable empirical sensing parameter. The Mie scattering properties of Cu
2
O particles, particularly the spectral dependence of the MDR on n
m
, are theoretically modeled to support the experimental observations. MDR extinction changes (i.e., refractive index sensitivity) per particle are >100 times higher compared to localized surface plasmon resonance (LSPR) changes in supported Au nanoislands, encouraging the evaluation of Cu
2
O and other high-n dielectric particles and sensing modes in order to improve the sensitivity in optical (bio)sensing applications.
ACS
Appl Mater Interfaces 2017 Mar 08
PMID:Refractive Index Sensing Using Visible Electromagnetic Resonances of Supported Cu
2
O Particles. 2813 59